{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,3,16]],"date-time":"2023-03-16T04:33:16Z","timestamp":1678941196612},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2023,1,28]],"date-time":"2023-01-28T00:00:00Z","timestamp":1674864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,1,28]],"date-time":"2023-01-28T00:00:00Z","timestamp":1674864000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Cardiol Rep"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1007\/s11886-023-01840-7","type":"journal-article","created":{"date-parts":[[2023,1,28]],"date-time":"2023-01-28T13:10:21Z","timestamp":1674911421000},"page":"147-156","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Comparison of the Recent Updates to the ACC\/AHA and ESC Guidelines for the Management of Valvular Heart Disease: Similarities and Differences"],"prefix":"10.1007","volume":"25","author":[{"given":"Nabila","family":"Laskar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sveeta","family":"Badiani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Treibel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanjeev","family":"Bhattacharyya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guy","family":"Lloyd","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,1,28]]},"reference":[{"issue":"9540","key":"1840_CR1","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1016\/S0140-6736(06)69208-8","volume":"368","author":"VT Nkomo","year":"2006","unstructured":"Nkomo VT, Gardin JM, Skelton TN, Gottdiener JS, Scott CG, Enriquez-Sarano M. Burden of valvular heart diseases: a population-based study. Lancet. 2006;368(9540):1005\u201311.","journal-title":"Lancet"},{"key":"1840_CR2","doi-asserted-by":"crossref","unstructured":"\u2022 Binder RK, Dweck M, Prendergast B. The year in cardiology: valvular heart disease. Eur Heart J. 2020;41(8):912\u201320. This paper provides an overview of the recent advances in diagnostic imaging and interventional techniques that have taken place over the last few years. It includes summaries of the seminal trials that have shaped recent guidelines.","DOI":"10.1093\/eurheartj\/ehz948"},{"key":"1840_CR3","doi-asserted-by":"crossref","unstructured":"Roth GA, Mensah GA, Johnson CO, Addolorato G, Ammirati E, et al. Global burden of cardiovascular diseases and risk factors, 1990-2019: update from the GBD 2019 study. J Am Coll Cardiol. 2020;76(25):2982-3021.","DOI":"10.1016\/j.jacc.2020.11.010"},{"key":"1840_CR4","doi-asserted-by":"crossref","unstructured":"Eleid MF, Michelena HI, Nkomo VT, Nishimura RA, Malouf JF, Scott CG, et al. Causes of death and predictors of survival after aortic valve replacement in low flow vs. normal flow severe aortic stenosis with preserved ejection fraction. Eur Heart J Cardiovasc Imaging. 2015;16(11):1270\u20135.","DOI":"10.1093\/ehjci\/jev091"},{"key":"1840_CR5","doi-asserted-by":"crossref","unstructured":"Kadem L, Dumesnil JG, Rieu R, Durand LG, Garcia D, Pibarot P. Impact of systemic hypertension on the assessment of aortic stenosis. Heart. 2005;91(3):354\u201361.","DOI":"10.1136\/hrt.2003.030601"},{"issue":"12","key":"1840_CR6","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1161\/CIRCULATIONAHA.113.005275","volume":"128","author":"BR Lindman","year":"2013","unstructured":"Lindman BR, Otto CM. Time to treat hypertension in patients with aortic stenosis. Circulation. 2013;128(12):1281\u20133.","journal-title":"Circulation"},{"key":"1840_CR7","unstructured":"Cowell-2005-A-randomized-trial-of-intensive-lip.pdf."},{"issue":"2","key":"1840_CR8","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1161\/CIRCULATIONAHA.109.900027","volume":"121","author":"KL Chan","year":"2010","unstructured":"Chan KL, Teo K, Dumesnil JG, Ni A, Tam J, Investigators A. Effect of lipid lowering with rosuvastatin on progression of aortic stenosis: results of the aortic stenosis progression observation: measuring effects of rosuvastatin (ASTRONOMER) trial. Circulation. 2010;121(2):306\u201314.","journal-title":"Circulation"},{"issue":"8","key":"1840_CR9","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1136\/heartjnl-2017-311738","volume":"104","author":"T Ochiai","year":"2018","unstructured":"Ochiai T, Saito S, Yamanaka F, Shishido K, Tanaka Y, Yamabe T, et al. Renin-angiotensin system blockade therapy after transcatheter aortic valve implantation. Heart. 2018;104(8):644\u201351.","journal-title":"Heart"},{"key":"1840_CR10","doi-asserted-by":"crossref","unstructured":"Dahl JS, Eleid MF, Michelena HI, Scott CG, Suri RM, Schaff HV, et al. Effect of left ventricular ejection fraction on postoperative outcome in patients with severe aortic stenosis undergoing aortic valve replacement. Circ Cardiovasc Imaging. 2015;8(4).","DOI":"10.1161\/CIRCIMAGING.114.002917"},{"key":"1840_CR11","doi-asserted-by":"crossref","unstructured":"Bohbot Y, de Meester de Ravenstein C, Chadha G, Rusinaru D, Belkhir K, Trouillet C, et al. Relationship between left ventricular ejection fraction and mortality in asymptomatic and minimally symptomatic patients with severe aortic stenosis. JACC Cardiovasc Imaging. 2019;12(1):38\u201348.","DOI":"10.1016\/j.jcmg.2018.07.029"},{"issue":"7","key":"1840_CR12","doi-asserted-by":"publisher","first-page":"4505","DOI":"10.21037\/jtd.2018.06.150","volume":"10","author":"M Madigan","year":"2018","unstructured":"Madigan M, Atoui R. Non-transfemoral access sites for transcatheter aortic valve replacement. J Thorac Dis. 2018;10(7):4505\u201315.","journal-title":"J Thorac Dis"},{"issue":"3","key":"1840_CR13","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1016\/0735-1097(95)00525-0","volume":"27","author":"E Klodas","year":"1996","unstructured":"Klodas E, Enriquez-Sarano M, Tajik AJ, Mullany CJ, Bailey KR, Seward JB. Aortic regurgitation complicated by extreme left ventricular dilation: Long-term outcome after surgical correction. J Am Coll Cardiol. 1996;27(3):670\u20137.","journal-title":"J Am Coll Cardiol"},{"key":"1840_CR14","unstructured":"Bonow-1991-Serial-long-term-assessment-of-the-.pdf."},{"issue":"27","key":"1840_CR15","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","volume":"37","author":"P Ponikowski","year":"2016","unstructured":"Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JGF, Coats AJS, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2016;37(27):2129\u2013200.","journal-title":"Eur Heart J"},{"issue":"12","key":"1840_CR16","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1016\/j.jacc.2018.01.054","volume":"71","author":"HB Ribeiro","year":"2018","unstructured":"Ribeiro HB, Lerakis S, Gilard M, Cavalcante JL, Makkar R, Herrmann HC, et al. Transcatheter aortic valve replacement in patients with low-flow, low-gradient aortic stenosis: the TOPAS-TAVI registry. J Am Coll Cardiol. 2018;71(12):1297\u2013308.","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"1840_CR17","doi-asserted-by":"publisher","first-page":"959","DOI":"10.21037\/jtd.2019.01.87","volume":"11","author":"W Zuo","year":"2019","unstructured":"Zuo W, Yang M, He Y, Hao C, Chen L, Ma G. Single or dual antiplatelet therapy after transcatheter aortic valve replacement: an updated systemic review and meta-analysis. J Thorac Dis. 2019;11(3):959\u201368.","journal-title":"J Thorac Dis"},{"issue":"16","key":"1840_CR18","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1016\/j.jcin.2019.03.003","volume":"12","author":"D Jochheim","year":"2019","unstructured":"Jochheim D, Barbanti M, Capretti G, Stefanini GG, Hapfelmeier A, Zadrozny M, et al. Oral anticoagulant type and outcomes after transcatheter aortic valve replacement. JACC Cardiovasc Interv. 2019;12(16):1566\u201376.","journal-title":"JACC Cardiovasc Interv"},{"issue":"9","key":"1840_CR19","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1016\/j.jacc.2019.06.058","volume":"74","author":"T Chakravarty","year":"2019","unstructured":"Chakravarty T, Patel A, Kapadia S, Raschpichler M, Smalling RW, Szeto WY, et al. Anticoagulation after surgical or transcatheter bioprosthetic aortic valve replacement. J Am Coll Cardiol. 2019;74(9):1190\u2013200.","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"1840_CR20","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1056\/NEJMoa1911425","volume":"382","author":"GD Dangas","year":"2020","unstructured":"Dangas GD, Tijssen JGP, Wohrle J, Sondergaard L, Gilard M, Mollmann H, et al. A controlled trial of rivaroxaban after transcatheter aortic-valve replacement. N Engl J Med. 2020;382(2):120\u20139.","journal-title":"N Engl J Med"},{"key":"1840_CR21","doi-asserted-by":"crossref","unstructured":"\u2022\u2022 Collet JP, Van Belle E, Thiele H, Berti S, Lhermusier T, Manigold T, et al. Apixaban vs. standard of care after transcatheter aortic valve implantation: the ATLANTIS trial. Eur Heart J. 2022;43(29):2783\u201397. The findings from this study show non inferiority when comparing apixaban to standard of care (antiplatelet or vitamin K antagonist) following TAVI, irrespective of the indication for oral anticoagulation.","DOI":"10.1093\/eurheartj\/ehac408"},{"key":"1840_CR22","doi-asserted-by":"crossref","unstructured":"Regitz-Zagrosek V, Roos-Hesselink JW, Bauersachs J, Blomstrom-Lundqvist C, Cifkova R, De Bonis M, et al. 2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy. Eur Heart J. 2018;39(34):3165\u2013241.","DOI":"10.1093\/eurheartj\/ehy340"}],"container-title":["Current Cardiology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11886-023-01840-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11886-023-01840-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11886-023-01840-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,16]],"date-time":"2023-03-16T01:03:33Z","timestamp":1678928613000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11886-023-01840-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,28]]},"references-count":22,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["1840"],"URL":"https:\/\/doi.org\/10.1007\/s11886-023-01840-7","relation":{},"ISSN":["1523-3782","1534-3170"],"issn-type":[{"value":"1523-3782","type":"print"},{"value":"1534-3170","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,28]]},"assertion":[{"value":"9 December 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Nabila Laskar reports salary support from Medtronic (2020\u20132021); Funding from Barts Charity. They are also currently conducting a pilot study on valvular heart disease incidence in the community, this will form part of a higher research degree (2020\u20132023) related to patents planned, issued, or pending. Funding from Barts Charity has contributed to the purchase of echocardiography devices for current service evaluation programme to identify valvular heart disease in the community. Thomas Treibel reports research grants from British Heart Foundation, European Commission, Academy of Medical Science, Barts Charity, UCH\/UCLH Biomedical Research Centre; Educational grant from Pfizer; Member of Data Safety Monitoring Board for Bypass CTCA; and Board member of the British Society of Cardiac Magnetic Resonance. Guy Lloyd reports consulting fees from GE; payment or honoraria from Edwards, Jannsen, Siemens, and GE; leadership or fiduciary role in British Cardiovascular Society; and research support from Medtronic. The other authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}]}}